1. Home
  2. VRME vs TOVX Comparison

VRME vs TOVX Comparison

Compare VRME & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.72

Market Cap

9.2M

Sector

Technology

ML Signal

HOLD

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.24

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
TOVX
Founded
1999
2001
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
10.1M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
VRME
TOVX
Price
$0.72
$0.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$1.50
$1.00
AVG Volume (30 Days)
40.2K
456.9K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.07
EPS
N/A
N/A
Revenue
$16,398,000.00
N/A
Revenue This Year
$36.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.16
52 Week High
$1.51
$0.86

Technical Indicators

Market Signals
Indicator
VRME
TOVX
Relative Strength Index (RSI) 58.20 54.29
Support Level $0.66 $0.22
Resistance Level $0.74 $0.26
Average True Range (ATR) 0.04 0.01
MACD 0.00 0.00
Stochastic Oscillator 83.47 54.52

Price Performance

Historical Comparison
VRME
TOVX

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Share on Social Networks: